Last reviewed · How we verify

NCT05753137

Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial

Recruiting now NA Last updated 3 July 2024
What this trial tests

NA trial testing Acupuncture in Glaucoma in 50 participants. Currently enrolling.

Timeline
28 June 2023
Primary endpoint
27 June 2025
27 June 2025

Quick facts

Lead sponsorChina Medical University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment50
Start date28 June 2023
Primary completion27 June 2025
Estimated completion27 June 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University Hospital

Who can join

20 and older, any sex, with Glaucoma or Acupuncture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients. A randomized, controlled trial involving 50 subjects will be conducted and observed for 12 weeks to evaluate the clinical efficacy of acupuncture. This study aims to provide a reference for future clinical treatment guidelines.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial.
    Liao YF, Lee YC, Lin HJ, Shao YC. · · 2024 · cited 4× · PMID 39378079 · DOI 10.2196/57888

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

Other recruiting trials for Glaucoma

Currently open trials in the same condition.

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05753137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing